Werewolf Therapeutics
HOWL | NASDAQ
$0.99
+$0.01 (+0.99%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
$0.00 (+0.08%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+0.99%
(1D)No price chart data available for 1D timeframe.
Rating
37.5
+1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #594/1021 (Top 58%)
Key Statistics
Market Data
Market Cap $48.15M
1D Range
0.95 1.00
52W Range
0.31 1.10
Valuation (TTM)
PE -1.74
PB 7.12
EV/EBITDA -0.41
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $1.00
Cash Flow
FCF Yield -49.8%
SBC Adj. FCF Yield -55.8%
SBC Impact -12.1%
Margins
Gross Margin 80.4%
Operating Margin -90.9%
FCF Margin -114.1%
Growth (CAGR)
Revenue 3Y | 5Y -6.5% |
-1.7%
Dil EPS 3Y | 5Y 37.8% |
18.5%
FCF 3Y | 5Y 25.5% |
4.3%
Returns
ROA -65.8%
ROE -187.3%
ROIC -282.5%
Financial Health
Net Cash
$41.87M
Current Ratio 1.19
Interest Coverage -5.94
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the...
Sector Healthcare
Industry Biotechnology
Employees 39
IPO Date Apr 30, 2021
Website werewolftx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$1.00
Upside
+1.01%
Buy (2)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove HOWL